SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023845
Filing Date
2022-11-09
Accepted
2022-11-09 16:10:12
Documents
56
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktx-20220930.htm   iXBRL 10-Q 2941643
2 EX-31.1 nktx-ex31_1.htm EX-31.1 22309
3 EX-31.2 nktx-ex31_2.htm EX-31.2 21661
4 EX-32 nktx-ex32.htm EX-32 21314
  Complete submission text file 0000950170-22-023845.txt   8638387

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktx-20220930.xsd EX-101.SCH 39480
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktx-20220930_lab.xml EX-101.LAB 381515
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktx-20220930_cal.xml EX-101.CAL 43797
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktx-20220930_def.xml EX-101.DEF 142831
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktx-20220930_pre.xml EX-101.PRE 268016
50 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20220930_htm.xml XML 1592461
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39370 | Film No.: 221372653
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences